Cargando…
Sweet Syndrome Following SARS-CoV2 Vaccination
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...
Autores principales: | Baffa, Maria Efenesia, Maglie, Roberto, Giovannozzi, Neri, Montefusco, Francesca, Senatore, Stefano, Massi, Daniela, Antiga, Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622799/ https://www.ncbi.nlm.nih.gov/pubmed/34835143 http://dx.doi.org/10.3390/vaccines9111212 |
Ejemplares similares
-
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?
por: Maglie, Roberto, et al.
Publicado: (2022) -
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
por: Baffa, Maria Efenesia, et al.
Publicado: (2022) -
Localized pemphigus exacerbation associated with underlying breast cancer
por: Maglie, Roberto, et al.
Publicado: (2020) -
Inverted‐U serration pattern: a novel clue for the diagnosis of anti‐laminin‐γ1 pemphigoid
por: Senatore, Stefano, et al.
Publicado: (2021) -
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)